Novateor Research Laboratories
add_icon

Novateor Research Laboratories

35.10
0.00
(0.00%)
Market Cap
21.20 Cr
PE Ratio
206.47
Volume
0.00
Day High - Low
- - -
52W High-Low
35.10 - 20.08
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
21.20 Cr
EPS
0.17
PE Ratio
206.47
PB Ratio
1.90
Book Value
18.51
EBITDA
0.40
Dividend Yield
0.00 %
Return on Equity
0.88
Debt to Equity
0.09
Forecast For
Actual

Company News

View All News
Caret
neutral
Novateor Research Laboratories reported a 24% rise in net profit to ₹10.12 lakh for FY26. Revenue grew 38% to ₹382.75 lakh. However, auditors issued a qualified opinion citing inventory and revenue recognition deviations.
neutral
Novateor Research Laboratories board approves AGM notice, auditor appointments, and proposed shift of registered office. The 15th AGM is scheduled for September 29, 2026.
neutral
Novateor Research Laboratories Limited has scheduled a board meeting for September 3, 2026, to consider the annual general meeting and other business matters.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
867.50
#1 88,766.47
47.27
#1 15,444.10
7.90
1,862
11.49
33.56
386.80
68,616.48
35.07
13,792.30
5.18
#1 1,869
15.33
46.81
1,892.00
51,459.68
38.04
6,124.20
-0.89
1,325
7.02
51.43
251.30
33,791.32
259.85
391.40
#1 92.62
108
#1 194.67
36.82
7,426.00
24,105.34
30.78
4,332.90
27.00
857
-34.25
22.84
7,048.00
22,966.06
34.55
3,127.40
38.21
654
9.40
29.69
380.60
16,613.19
#1 21.44
3,864.60
-0.33
775
-15.46
49.87
473.60
15,440.51
62.69
2,475.50
15.37
200
118.89
51.11
515.30
6,730.76
30.03
1,191.80
19.13
190
84.86
52.88
1,083.70
2,063.88
60.55
138.30
79.38
34
-
46.64
Growth Rate
Revenue Growth
30.30 %
Net Income Growth
-
Cash Flow Change
82.52 %
ROE
12.82 %
ROCE
-
EBITDA Margin (Avg.)
-16.02 %

Yearly Financial Results

Annual Financials
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
TTM
Revenue
0
0
0
0
1
1
1
1
2
2
3
4
0
Expenses
0
0
0
0
0
1
1
1
2
2
3
4
0
EBITDA
0
0
0
0
0
0
0
0
0
0
0
0
0
Operating Profit %
2 %
-6 %
42 %
59 %
71 %
-35 %
-176 %
-25 %
-28 %
-27 %
-5 %
-3 %
-39 %
Depreciation
0
0
0
0
0
0
0
0
0
0
0
0
0
Interest
0
0
0
0
0
0
0
0
0
0
0
0
0
Profit Before Tax
0
0
0
0
0
0
0
-0
0
0
0
0
0
Tax
0
0
0
0
0
0
0
0
0
0
0
0
0
Net Profit
0
0
0
0
0
0
0
-0
0
0
0
0
0
EPS in ₹
0.30
0.05
-0.62
0.18
0.74
-0.02
0.02
-0.47
0.08
0.06
0.17
0.17
-0.00

Order Value Trend

FY 2026-27 order value₹0.08 Cr
FY 2026-271 Orders
Smart Laboratories Private Lim...
100.00%

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Total Assets
2
2
2
2
4
9
9
8
9
11
13
14
Fixed Assets
2
2
2
2
4
4
3
2
2
2
3
3
Current Assets
0
0
0
0
1
5
6
6
7
8
9
11
Capital Work in Progress
0
0
0
0
0
0
0
0
0
0
0
0
Investments
0
0
0
0
0
0
0
0
0
0
0
0
Other Assets
0
0
0
0
1
5
6
6
7
8
9
11
Total Equity & Liabilities
2
2
2
2
4
9
9
8
9
11
13
14
Current Liabilities
0
0
0
0
0
0
0
0
1
1
2
2
Non Current Liabilities
1
1
1
1
0
0
0
0
0
1
0
0
Total Equity
1
1
1
1
4
9
9
8
8
9
11
12
Reserve & Surplus
1
1
1
1
1
4
4
3
3
4
3
6
Share Capital
0
0
0
0
3
5
5
5
5
5
5
6

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Net Cash Flow
0
0
0
0
0
1
0
-0
-0
-0
0
0
Investing Activities
0
0
0
0
-2
-0
-0
1
0
-0
-0
-1
Operating Activities
0
0
0
0
-0
-3
-0
-1
-1
-1
-1
-0
Financing Activities
0
0
0
0
2
4
0
-0
1
1
1
1

Share Holding

% Holding
Mar 2021
Sept 2021
Mar 2022
Sept 2022
Mar 2023
Sept 2023
Mar 2024
Sept 2024
Mar 2025
Sept 2025
Mar 2026
Promoter
60.87 %
60.87 %
60.87 %
60.87 %
60.87 %
60.87 %
60.87 %
60.87 %
51.60 %
50.90 %
50.75 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
30.61 %
28.73 %
30.86 %
25.77 %
26.52 %
26.89 %
27.14 %
26.52 %
29.11 %
29.90 %
30.00 %
Others
8.51 %
10.40 %
8.27 %
13.36 %
12.61 %
12.24 %
11.99 %
12.61 %
19.29 %
19.19 %
19.24 %
No of Share Holders
164
146
138
118
113
118
122
160
164
172
172

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
29 Sept 2026 ANNUAL GENERAL MEETING Annual General Meeting
NA
29 Sept 2026 32.00 35.10
03 Dec 2023 EXTRAORDINARY GENERAL MEETING Extraordinary General Meeting
NA
03 Dec 2023 31.70 28.00
20 Jul 2024 EXTRAORDINARY GENERAL MEETING Extraordinary General Meeting
NA
20 Jul 2024 43.75 47.50
28 Sept 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
28 Sept 2024 53.27 52.30
14 Nov 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
14 Nov 2024 52.30 51.25
30 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
30 May 2025 57.50 57.50
30 Sept 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
30 Sept 2025 31.48 24.50
14 Nov 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
14 Nov 2025 26.00 26.00
30 May 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
30 May 2026 32.85 32.85

Announcements

Reg. 34 (1) Annual Report.Sep 05, 2026
Notice Of 15Th Annual General Meeting Of The CompanySep 05, 2026
The Cut Off Date To Determine Eligible Shareholders Who Can Attend The 15Th Annual General Meeting Of The CompanySep 03, 2026
15Th Annual General Meeting Of The CompanySep 03, 2026
Appointment Of Secretarial Auditor And Internal Auditor Of The Company.Sep 03, 2026
Board Meeting Outcome for Outcome Of Board Meeting Of The Board Of Directors Held On Thursday September 03 2026Sep 03, 2026
Board Meeting Intimation for Approval Of Agenda Related To Ensuing AGM And Other Businesses With The Permission Of ChairmanAug 31, 2026
The Company Has Entered Into Marketer And Manufacturing Agreement With Smart Laboratories Private LimitedAug 20, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Aug 15, 2026
Launch Of New Product- Smiloshine Herbafresh Toothpaste Formulated With 8 Herbs 6 Grams SachetJun 15, 2026
Board Meeting Outcome for Approval And Adoption Of Audited Financial Results For The Half Year And Year Ended On March 31 2026May 30, 2026
Board Meeting Intimation for Adoption Of Audited Financial Results For The Half Year And Year Ended On March 31 2026May 26, 2026
Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2Apr 30, 2026
Launch Of New Product- Smiloshine Herbafresh ToothpasteApr 30, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 07, 2026
Closure of Trading WindowMar 31, 2026
Launch Of New Product- Smiloshine Aligner And Denture Cleaner And Whitener FoamFeb 11, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 16, 2026
Unaudited Financial Results For The Half Year Ended On 30.09.2025Nov 14, 2025
Board Meeting Outcome for Unaudited Financial Results For The Half Year Ended On September 30 2025Nov 14, 2025
Board Meeting Intimation for Adoption Of Financial Results For The Half Year Ended On September 30 2025Nov 08, 2025
Appointment of Company Secretary and Compliance OfficerNov 03, 2025
Non Applicability Of Submission Of Related Party Disclosures For The Half Year Ended On September 30 2025 Oct 06, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 06, 2025
Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of AssociationSep 30, 2025
Announcement under Regulation 30 (LODR)-Change in DirectorateSep 30, 2025
Shareholder Meeting / Postal Ballot-Outcome of AGMSep 30, 2025
Closure of Trading WindowSep 30, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Sep 17, 2025
Reg. 34 (1) Annual Report.Sep 08, 2025
Notice Of 14Th AGM Of The CompanySep 08, 2025
The Cut Off Date To Determine The Eligible Shareholders Who Can Attend The 14Th AGM Of The CompanySep 03, 2025
14Th Annual General Meeting Of The CompanySep 03, 2025
Announcement under Regulation 30 (LODR)-Change in DirectorateSep 03, 2025
Reappointment Of Secretarial Auditor And Internal Auditor Of The CompanySep 03, 2025
Board Meeting Outcome for Outcome Of The Board Meeting Held On Today September 03 2025Sep 03, 2025
Board Meeting Intimation for Approval Of Agenda Related To Ensuing AGM And Other Businesses With The Permission Of ChairmanAug 31, 2025
Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance OfficerJul 30, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 12, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Jun 02, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Jun 02, 2025
Announcement under Regulation 30 (LODR)-AllotmentMay 30, 2025
Audited Financial Results For The Half Year And Year Ended On 31.03.2025May 30, 2025
Board Meeting Outcome for Outcome Of Board MeetingMay 30, 2025
Board Meeting Intimation for For The Adoption Of Financial Results Of The CompanyMay 24, 2025
Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2May 15, 2025
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure AApr 30, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 11, 2025
Launch Of Smiloshine Teeth Whitening Mouthwash With Activated CharcoalApr 04, 2025
Closure of Trading WindowMar 29, 2025

Technical Indicators

RSI(14)
Neutral
55.69
ATR(14)
Less Volatile
2.22
STOCH(9,6)
Neutral
69.97
STOCH RSI(14)
Overbought
90.84
MACD(12,26)
Bullish
1.05
ADX(14)
Weak Trend
14.35
UO(9)
Bearish
65.14
ROC(12)
Uptrend And Accelerating
46.25
WillR(14)
Overbought
0.00